Ion Beam Applications SA (IOBCF)
OTCMKTS · Delayed Price · Currency is USD
11.15
-2.55 (-18.61%)
May 12, 2025, 4:00 PM EDT

Ion Beam Applications Company Description

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally.

It operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems.

This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization.

The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures.

The company has strategic research and development partnership with SCK CEN, a Belgian nuclear research center focusing on the development of Actinium-225, a radioactive isotope for the treatment of cancer.

It Also develops ConformalFLASH, a novel technique using the proton Bragg peak. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

Ion Beam Applications SA
Ion Beam Applications logo
Country Belgium
Founded 1986
Industry Medical Devices
Sector Healthcare
Employees 2,287
CEO Olivier Legrain

Contact Details

Address:
3, Chemin du Cyclotron
Louvain-la-Neuve, 1348
Belgium
Phone 32 1 047 58 11
Website iba-worldwide.com

Stock Details

Ticker Symbol IOBCF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency EUR
ISIN Number BE0003766806
SIC Code 3845

Key Executives

Name Position
Henri de Romree Deputy Chief Executive Officer
Olivier Legrain Chief Executive Officer, MD and Executive Director
Pierre Mottet Chairman of The Board
Yves Jongen Founder, Chief Research Officer, MD and Executive Director
Olivier Lechien Corporate Communication Director
Thomas Canon Sustainability Program Director
Bruno Scutnaire President of IBA RadioPharma Solutions